Designs for Health, the trusted practitioner brand Learn More

GI Microbial Assay Plus (GI-MAP) Test

The ground-breaking test targeting vital markers for gastrointestinal health

GI-MAP TEST

THE SCIENCE  BEHIND THE GI-MAP

Gastrointestinal health is our cornerstone and the core of designing a wellness pathway for your patients.
That’s why Designs for Health focus is to develop science-based GI gut health mapping tools, leading-edge products, education and product protocols for healthcare practitioners and their patients.

Optimal Health Starts with the Science of GI-MAP

Quantitative PCR assay for GI pathogens

The GI-MAP™ (GI-Microbial Assay Plus) test is the first comprehensive stool analysis to include an FDA-approved DNA/PCR assay for GI pathogens performed on stool*. The pathogen targets include bacteria, parasites, and another first for the market – viruses. Using the same molecular technology, for microbe assays that are useful for integrative and functional medicine practitioners. And unlike previous PCR (polymerase chain reaction) assays, we have fully validated each target organism in our panel, so that you can have confidence in the results. GI-MAP™ tests for GI pathogens, opportunistic organisms, normal flora, and markers of GI health including:

  • Bacterial Pathogens
  • Viral Pathogens
  • Parasitic Pathogens
  • Fungi + Yeast
  • H Pylori + Virulence Factors
  • H Pylori Antibiotic Resistance Genes
  • Commensal Bacteria
  • Bacterial Phyla
  • Opportunistic Bacteria
  • Auto-Immune Related Bacteria
  • Commensal Inflammatory Bacteria
  • Elastase
  • Beta Glucoronidase
  • Occult Blood
  • SIgA
  • Anti Gliadin IgA
  • Eosinophil Activation Protein
  • Calprotectin

Explore References for the GI-MAPMarkers

Access References and Research Papers

To make this information easily accessible, we’ve structured it below in an accordion-style format. Simply click on the main sections to explore the markers within. For instance, under the “Pathogens” section, you will find specific markers such as Clostridia, each linked to relevant research articles.

This layout allows practitioners to quickly locate and review the scientific studies that validate each marker, ensuring that your interpretations and recommendations are backed by the latest research.

We hope this resource enhances your practice by providing reliable, evidence-based information at your fingertips.

GI-MAP– The Superior Solution

Other available stool tests may appear to be DNA-based, but they are, in fact, only using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) to identify stool microbes. Their methodology relies on cultures from the stool and is not molecular/PCR-based assays. With a culture-based test, it is not possible to measure strict anaerobes, viruses, or virulence factors. They also lack the ability to deliver true quantitation of any of the reported organisms.

In addition, other recent test offerings using an FDA-cleared molecular technology only for pathogens do not extend any molecular methodology over an entire comprehensive stool analysis to include opportunistic and beneficial organisms, including bacteria, protozoa, and fungi, all of which are provided through the GI-MAP™.

Many advances in DNA technology have occurred over the last ten years, including an FDA-approved PCR-based technology and assay used by major hospital labs. Considering these advances, why would you still rely on culture and microscopy for stool analysis and assessment of the GI environment?

GI-MAP™ Science Resources

GI-MAP TEST

GI-MAP Technical Markers and Scientific Information

Welcome to our comprehensive section on technical markers and references, specifically designed to help practitioners understand the research that underpins the GI-Map test report.

This section provides in-depth research data on each marker, organised to correlate with the main sections of the GI-Map test report. Research articles for each marker offer a scientific foundation for the test results.

Easy-Access Research Papers

To make this information easily accessible, we’ve structured it in an accordion-style format. Click on the main sections to explore the markers within. For instance, under the “Pathogens” section, specific markers, such as Clostridia, are each linked to relevant research articles.

This layout lets practitioners quickly locate and review the scientific studies that validate each marker, ensuring that your interpretations and recommendations are backed by the latest research.

Pathogens

+C. difficile
+E. coli
+Enterohemorrhagic E. coli
+0157
+Enteroinvasive E. coli
+Enterotoxigenic E. coli
+Shiga-like Toxin E. coli
+Salmonella
+Yersinia enterocolitica

Parasitic Pathogens

Viral Pathogens

Helicobacter Pylori

+Helicobacter Pylori
+Virulence factors

Commensals

+Commensals

  1. Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples – PMC (nih.gov)
  2. (PDF) What is the evidence for the use of probiotics in functional disorders? (researchgate.net)
  3. A Clinician’s Primer on the Role of the Microbiome in Human Health and Disease – Mayo Clinic Proceedings
  4. Diversity, stability and resilience of the human gut microbiota – PMC (nih.gov)
  5. Commensal Clostridia: leading players in the maintenance of gut homeostasis | Gut Pathogens | Full Text (biomedcentral.com)
  6. Nondigestible carbohydrates, butyrate, and butyrate-producing bacteria – PubMed (nih.gov)
  7. Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health | Microbiome | Full Text (biomedcentral.com)
  8. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases – PMC (nih.gov)
  9. Depletion of butyrate-producing Clostridia from the gut microbiota drives an aerobic luminal expansion of Salmonella – PMC (nih.gov)
  10. Gut-microbiota-targeted diets modulate human immune status: Cell
  11. Nature-Derived Microbiota Exposure as a Novel Immunomodulatory Approach: Future Microbiology: Vol 13 , No 7 – Get Access (tandfonline.com)
  12. American Gut: an Open Platform for Citizen Science Microbiome Research | mSystems (asm.org)
  13. Medicine & Science in Sports & Exercise (lww.com)
  14. Clinical and Translational Gastroenterology (lww.com)
  15. Associations of healthy food choices with gut microbiota profiles – ScienceDirect

+Bacteroides fragilis
+Bifidobacterium spp.& Lactobacillus spp.
+Enterococcus spp.
+Escherichia spp
+Enterobacter spp
+Akkermansia muciniphila
+Faecalibacterium prausnitzii
+Roseburia spp.

Phyla

Opportunistics

+Pseudomonas spp.
+Desulfovibrio spp.
+Methanobacteriaceae

Auto Immune Bacteria

+Auto Immune bacteria

  1. Infection, thyroid disease, and autoimmunity – PubMed (nih.gov)
  2. [Antibodies to Yersinia enterocolitica in immunogenic thyroid diseases] – PubMed (nih.gov)
  3. Intestinal permeation and gastrointestinal disease – PubMed (nih.gov)
  4. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. – Abstract – Europe PMC
  5. Antibody responses to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn’s disease and ulcerative colitis | Rheumatology International (springer.com)
  6. Ankylosing Spondylitis and Undifferentiated Spondyloarthropathy: Practice Essentials, Background, Pathophysiology (medscape.com)
  7. Rheumatoid Arthritis is an Autoimmune Disease Triggered by Proteus Urinary Tract Infection – PMC (nih.gov)
  8. Rheumatoid arthritis: proposal for the use of anti‐microbial therapy in early cases: Scandinavian Journal of Rheumatology: Vol 32, No 1 (tandfonline.com)
  9. Microbial factors in spondyloarthropathies: insights from population studies – PubMed (nih.gov)
  10. Management of reactive arthritis: Expert Opinion on Pharmacotherapy: Vol 5, No 1 (tandfonline.com)
  11. 305.pdf (microbiologyresearch.org)
  12. Enteropathic Arthropathies: Practice Essentials, Etiology, Epidemiology (medscape.com)
  13. 30-kDa band from Salmonella typhimurium: IgM, IgA and IgG antibody response in patients with ankylosing spondylitis | Rheumatology | Oxford Academic (oup.com)
  14. Reactive Arthritis: Practice Essentials, Background, Pathophysiology (medscape.com)
  15. Update on the Gastrointestinal Microbiome in Systemic Sclerosis | Current Rheumatology Reports (springer.com)

+Fusobacterium spp.
+Proteus spp.
+Proeteus mirabalis

Fungal

Viruses

+Cytomegalovirus
+Epstein-Barr Virus
+Blastocystis hominis
+Cyclospora spp.
+Dientamoeba fragilis
+Pentatrichomonas hominis

Worms

+Ancylostoma duodenale
+Ascaris lumbricoides
+Trichuris trichiura
+Taenia spp.

Intestinal Health

+Steatocrit
+Elastase-1
+β-Glucuronidase
+Occult Blood
+Secretory IgA
+Therapeutic Interventions
+Anti gliadin IgA
+Eosinophil Activation Protein
+Calprotectin
+Zonulin
+Therapeutic Interventions | One

  1. Antibacterial effect of Allium sativum cloves and Zingiber officinale rhizomes against multiple-drug resistant clinical pathogens – PMC (nih.gov)
  2. Inhibitory effect of Allium sativum and Zingiber officinale extracts on clinically important drug resistant pathogenic bacteria – PMC (nih.gov)
  3. Randomized Controlled Trial of Berberine Sulfate Therapy for Diarrhea Due to Enterotoxigenic Escherichia coli and Vibrio cholerae | The Journal of Infectious Diseases | Oxford Academic (oup.com)
  4. Berberine Monograph (altmedrev.com)
  5. Allylsulfide constituents of garlic volatile oil as antimicrobial agents – ScienceDirect
  6. Comparing the Therapeutic Effects of Garlic Tablet and Oral Metronidazole on Bacterial Vaginosis: A Randomized Controlled Clinical Trial – PMC (nih.gov)
  7. In vitro effects of food extracts on selected probiotic and pathogenic bacteria – PubMed (nih.gov)
  8. A COMPARATIVE ASSESSMENT OF THE ANTIMICROBIAL EFFECTS OF GARLIC (ALLIUM SATIVUM) AND ANTIBIOTICS ON DIARRHEAGENIC ORGANISMS
  9. In vitro antimicrobial activity of olive leaves. Antimikrobielle Wirksamkeit von Olivenblättern in vitro – Markin – 2003 – Mycoses – Wiley Online Library
  10. An evaluation of the inhibitory effects against rotavirus infection of edible plant extracts | Virology Journal | Full Text (biomedcentral.com)
  11. Gut microbiota richness promotes its stability upon increased dietary fibre intake in healthy adults – Tap – 2015 – Environmental Microbiology – Wiley Online Library
  12. Associations of healthy food choices with gut microbiota profiles – ScienceDirect
  13. Pomegranate Metabolites Impact Tryptophan Metabolism in Humans and Mice – Current Developments in Nutrition
  14. Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study | Scientific Reports (nature.com)

+Therapeutic Interventions | Two

  1. Untargeted plasma metabolomic profiles associated with overall diet in women from the SU.VI.MAX cohort | European Journal of Nutrition (springer.com)
  2. Behaviour of citrus pectin during its gastrointestinal digestion and fermentation in a dynamic simulator (simgi®) – ScienceDirect
  3. Prebiotic effects of pectooligosaccharides obtained from lemon peel on the microbiota from elderly donors using an in vitro continuous colon model (TIM-2) – Food & Function (RSC Publishing)
  4. In vitro characterization of the impact of selected dietary fibers on fecal microbiota composition and short chain fatty acid production – ScienceDirect
  5. IJMS | Free Full-Text | A Small In Vitro Fermentation Model for Screening the Gut Microbiota Effects of Different Fiber Preparations (mdpi.com)
  6. Nutrients | Free Full-Text | Fermentation Profiles of Wheat Dextrin, Inulin and Partially Hydrolyzed Guar Gum Using an in Vitro Digestion Pretreatment and in Vitro Batch Fermentation System Model (mdpi.com)
  7. comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides | Journal of Applied Microbiology | Oxford Academic (oup.com)
  8. Development of a prebiotic blend to influence in vitro fermentation effects, with a focus on propionate, in the gut | FEMS Microbiology Ecology | Oxford Academic (oup.com)
  9. Comparative prebiotic activity of mixtures of cereal grain polysaccharides | AMB Express | Full Text (springeropen.com)
  10. In Vitro Batch Fecal Fermentation Comparison of Gas and Short‐Chain Fatty Acid Production Using “Slowly Fermentable” Dietary Fibers – Kaur – 2011 – Journal of Food Science – Wiley Online Library
  11. Nutrients | Free Full-Text | In Vitro Fecal Fermentation Patterns of Arabinoxylan from Rice Bran on Fecal Microbiota from Normal-Weight and Overweight/Obese Subjects (mdpi.com)
  12. Determination of the prebiotic activity of wheat arabinogalactan peptide (AGP) using batch culture fermentation | European Journal of Nutrition (springer.com)
  13. Microorganisms | Free Full-Text | Gut Microbial Protein Expression in Response to Dietary Patterns in a Controlled Feeding Study: A Metaproteomic Approach (mdpi.com)
  14. Consumption of partially hydrolysed guar gum stimulates Bifidobacteria and butyrate-producing bacteria in the human large intestine in: Beneficial Microbes Volume 6 Issue 4 (2015) (brill.com)